The tumor was American Joint Committee on Cancer stage T2 MX NX, Grade Group 1 (GG1), and the initial total prostate-specific antigen (PSA) was 7.5 ng/mL (16% free PSA) at the time of diagnosis. Here, KLK3 is linked to neoplasm.